Giant-cell tumor of bone arising in the anterior rib with a positive expression of GPX-1: a case report and review of the literature

Fletcher C, Unni K, Mertens F (2002) Pathology and genetics tumours of soft tissue and bone. IARC, Lyon, pp 200–204

Szendroi M (2004) Giant-cell tumour of bone. J Bone Joint Surg Br 86(1):5–12

Suehara Y, Nozawa M, Kim SG, et al (2010) Late recurrence of giant cell tumour of bone after curettage and adjuvant treatment: a case report. J Orthop Surg (Hong Kong) 18(1):122–125

Gupta V, Mittal R (2000) Giant cell tumor of rib–rare location on the anterior aspect. Arch Orthop Trauma Surg 120(3–4):231–232

Hanna RM, Kyriakos M, Quinn SF (1992) Case report 757: giant cell tumor of rib. Skeletal Radiol 21(7):482–488

Sakao Y, Sakuragi T, Takeda Y, et al (2003) Giant cell tumor of the rib. Jpn J Thorac Cardiovasc Surg 51(10):537–540

Shin JS, Lee IS, Kim A, Kim BH (2002) Giant cell tumor originating from the anterior arc of the rib. J Korean Med Sci 17(6):849–851

Dehghan A, Moaddab AH, Eskandarlou M, Moeeni A (2010) Anterior chest wall giant cell tumor. Gen Thorac Cardiovasc Surg 58(1):39–41

Mogi A, Kosaka T, Yamaki E, et al (2012) Surgical resection and reconstruction for a giant cell tumor of the anterior rib. Gen Thorac Cardiovasc Surg 60(4):233–236

Cordeiro SZ, Pde Cordeiro B, Sousa AM, et al (2008) Giant cell tumor of the rib occupying the entire hemithorax. J Bras Pneumol 34(3):185–188

Riddle ND, Yamauchi H, Caracciolo JT, et al (2010) Giant cell tumor of the anterior rib masquerading as a breast mass: a case report and review of current literature. Cases J 3:51

Sharma A, Armstrong AE (2012) Giant cell tumor of rib arising anteriorly as a large inframammary mass: a case report and review of the literature. Case Rep Med 2012:850509

Goldenberg RR, Campbell CJ, Bonfiglio M (1970) Giant-cell tumor of bone. An analysis of two hundred and eighteen cases. J Bone Joint Surg Am 52(4):619–664

Takeuchi A, Tsuchiya H, Niu X, et al (2011) The prognostic factors of recurrent GCT: a cooperative study by the Eastern Asian Musculoskeletal Oncology Group. J Orthop Sci 16(2):196–202

Conti A, Rodriguez GC, Chiechi A, et al (2011) Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis. Am J Pathol 178(1):88–97

Okubo T, Saito T, Mitomi H, et al (2013) p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1. Virchows Arch 463(1):67–77

Saito T, Mitomi H, Izumi H, et al (2011) A case of secondary malignant giant-cell tumor of bone with p53 mutation after long-term follow-up. Hum Pathol 42(5):727–733

Saito T, Mitomi H, Suehara Y, et al (2011) A case of de novo secondary malignant giant-cell tumor of bone with loss of heterozygosity of p53 gene that transformed within a short-term follow-up. Pathol Res Pract 207(10):664–669

Branstetter DG, Nelson SD, Manivel JC, et al (2012) Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res 18(16):4415–4424

Thomas D, Henshaw R, Skubitz K, et al (2010) Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 11(3):275–280

Campanacci M (1976) Giant-cell tumor and chondrosarcomas: grading, treatment and results (studies of 209 and 131 cases). Recent Results Cancer Res 54:257–261

Capanna R, Fabbri N, Bettelli G (1990) Curettage of giant cell tumor of bone. The effect of surgical technique and adjuvants on local recurrence rate. Chir Organi Mov 75(1 Suppl):206

McDonald DJ, Sim FH, McLeod RA, Dahlin DC (1986) Giant-cell tumor of bone. J Bone Joint Surg Am 68(2):235–242

Atkins GJ, Kostakis P, Vincent C, et al (2006) RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J Bone Miner Res 21(9):1339–1349

Roux S, Amazit L, Meduri G, et al (2002) RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. Am J Clin Pathol 117(2):210–216

Werner M (2006) Giant cell tumour of bone: morphological, biological and histogenetical aspects. Int Orthop 30(6):484–489

Huang L, Teng XY, Cheng YY, et al (2004) Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone. Bone 34(3):393–401

Sul OJ, Kim JC, Kyung TW, et al (2010) Gold nanoparticles inhibited the receptor activator of nuclear factor-κb ligand (RANKL)-induced osteoclast formation by acting as an antioxidant. Biosci Biotechnol Biochem 74:2209–2213